| |
 |
|
Class Information
Number: 424/257.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Escherichia (e.g., escherichia coli, etc.)
Description: Subject matter wherein the bacterium is of the genus Escherichia.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7357935 |
Avian E. coli vaccine for protection against colibacillosis |
Apr. 15, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7323179 |
Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
Jan. 29, 2008 |
| 7320794 |
Transporter protein |
Jan. 22, 2008 |
| 7297338 |
Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella |
Nov. 20, 2007 |
| 7291325 |
Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
Nov. 6, 2007 |
| 7208574 |
Host receptor for pathogenic bacteria |
Apr. 24, 2007 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7147857 |
Methods for treating high somatic cell counts |
Dec. 12, 2006 |
| 7138125 |
Methods for treating an animal for low milk production |
Nov. 21, 2006 |
| 7138124 |
Polypeptides obtained from gram negative microbes |
Nov. 21, 2006 |
| 7118758 |
Transformed bacteria producing CS6 antigens as vaccines |
Oct. 10, 2006 |
| 7070781 |
Nontoxic mucosal adjuvant |
Jul. 4, 2006 |
| 7063852 |
Hybrid LT-A/CT-B holotoxin for use as an adjuvant |
Jun. 20, 2006 |
| 7056521 |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
Jun. 6, 2006 |
| 7037510 |
Hybrids of M. tuberculosis antigens |
May. 2, 2006 |
| 7025963 |
Vaccine against Gram-negative bacterial infections |
Apr. 11, 2006 |
| 7025971 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Apr. 11, 2006 |
| 7018636 |
Vaccine against Gram-negative bacterial infections |
Mar. 28, 2006 |
| 6962791 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Nov. 8, 2005 |
| 6942861 |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
Sep. 13, 2005 |
| 6913753 |
Incapacitated whole-cell immunogenic bacterial compositions |
Jul. 5, 2005 |
| 6905691 |
Vaccines containing attenuated bacteria |
Jun. 14, 2005 |
| 6902736 |
Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same |
Jun. 7, 2005 |
| 6872547 |
Functional balanced-lethal host-vector systems |
Mar. 29, 2005 |
| 6793928 |
Vaccines with an LTB adjuvant |
Sep. 21, 2004 |
| 6743607 |
Production of complex carbohydrates |
Jun. 1, 2004 |
| 6737063 |
FimH adhesin proteins and methods of use |
May. 18, 2004 |
| 6638513 |
Neisseria meningitidis serogroup B Glycoconjugates |
Oct. 28, 2003 |
| 6613321 |
Live vaccines against gram-negative pathogens, expressing heterologous O-antigens |
Sep. 2, 2003 |
| 6610529 |
Recombinant bacterial system with environmentally limited viability |
Aug. 26, 2003 |
| 6596283 |
Meningococcal polysaccharide conjugate vaccines |
Jul. 22, 2003 |
| 6558678 |
PREPARATION AND USE OF FORMALIN-KILLED COLONIZATION-FACTOR-ANTIGEN (CFA)-EXPRESSING E. COLI ORGANISMS FOR VACCINATION AGAINST ENTERIC INFECTION/DIARRHEA CAUSED BY ENTEROTOXIGENIC E. COLI BACTE |
May. 6, 2003 |
| 6500434 |
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections |
Dec. 31, 2002 |
| 6471966 |
Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof |
Oct. 29, 2002 |
| 6440423 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Aug. 27, 2002 |
| 6432412 |
Active immunization using a siderophore receptor protein |
Aug. 13, 2002 |
| 6420127 |
Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
Jul. 16, 2002 |
| 6395964 |
Oral immunization with transgenic plants |
May. 28, 2002 |
| 6368604 |
Non-pyrogenic derivatives of lipid A |
Apr. 9, 2002 |
| 6344201 |
Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogeni |
Feb. 5, 2002 |
| 6306404 |
Adjuvant and vaccine compositions containing monophosphoryl lipid A |
Oct. 23, 2001 |
| 6277383 |
Ryegrass pollen allergen |
Aug. 21, 2001 |
| 6221386 |
Use of virulence factors of pathogens to improve liposomal delivery of therapeutic agents |
Apr. 24, 2001 |
| 6217883 |
Porcine circovirus and paravovirus vaccine |
Apr. 17, 2001 |
| 6162433 |
Non antibiotic selectable markers for live vaccines |
Dec. 19, 2000 |
| 6153396 |
Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
Nov. 28, 2000 |
| 6149919 |
Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines |
Nov. 21, 2000 |
| 6121296 |
Transition-state inhibitors for nucleoside hydrolase and transferase reactions |
Sep. 19, 2000 |
|
|
|
